Skip to main content
Top
Published in: Surgery Today 9/2021

01-09-2021 | Metastasis | Original Article

Resection strategy for colorectal liver metastasis focusing on intrahepatic vessels and resection margins

Authors: Kentaro Iwaki, Satoshi Kaihara, Koji Kitamura, Kenji Uryuhara

Published in: Surgery Today | Issue 9/2021

Login to get access

Abstract

Purpose

We analyzed the impact of surgical margins and vessel preservation on the oncological outcomes of patients with colorectal liver metastases (CRLM).

Methods

In this retrospective study, resected CRLM (n = 242) from 116 patients were assigned to one of the following groups: Group A, apart from vessels (n = 201); Group B, hepatic vein contact (n = 27); or Group C, Glissonean pedicle contact (n = 25). We analyzed the local recurrence rates (LRR) in each group.

Results

The total LRR and that in Groups A, B, and C were 11.6%, 10.4%, 7.4%, and 20%, respectively. In group A, R1 resections were associated with a significantly higher LRR than R0 resections (27.6% vs 7.6%, respectively; P = 0.001); however, the margin widths were not related to the LRR. In group B, the LRR for hepatic vein preservation and resection did not differ. In group C, the Glissonean pedicle preservation group had a higher LRR than the Glissonean pedicle resection group (66.7% vs 5.3%, respectively; P = 0.001). The 5-year overall survival rate of the local recurrence group (25%) was significantly lower than that of the no recurrence group (84%, P < 0.001) and the intrahepatic recurrence group (60%, P = 0.026).

Conclusion

R0 resections for CRLM, apart from those involving vessels, can achieve local control. While preserving hepatic vein contact with CRLM is acceptable, the Glissonean pedicle should be resected because of the higher LRR.
Literature
1.
go back to reference Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–27.CrossRef Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–27.CrossRef
2.
go back to reference Park J, Lee SD, Han SS, Kim SH, Park SJ, Oh JH, et al. Repeat hepatectomy for recurred colorectal liver metastasis: is it justified? Ann Surg Treat Res. 2019;97:7–14.CrossRef Park J, Lee SD, Han SS, Kim SH, Park SJ, Oh JH, et al. Repeat hepatectomy for recurred colorectal liver metastasis: is it justified? Ann Surg Treat Res. 2019;97:7–14.CrossRef
4.
go back to reference Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002;137:833–40.CrossRef Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002;137:833–40.CrossRef
5.
go back to reference Truant S, Séquier C, Leteurtre E, Boleslawski E, Elamrani M, Huet G, et al. Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB. 2015;17:176–84.CrossRef Truant S, Séquier C, Leteurtre E, Boleslawski E, Elamrani M, Huet G, et al. Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. HPB. 2015;17:176–84.CrossRef
6.
go back to reference Ardito F, Panettieri E, Vellone M, Ferrucci M, Coppola A, Silvestrini N, et al. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: an analysis of 1,428 resection areas. Surg. 2019;165:712–20.CrossRef Ardito F, Panettieri E, Vellone M, Ferrucci M, Coppola A, Silvestrini N, et al. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: an analysis of 1,428 resection areas. Surg. 2019;165:712–20.CrossRef
7.
go back to reference Sasaki K, Margonis GA, Maitani K, Andreatos N, Wang J, Pikoulis E, et al. The prognostic impact of determining resection margin status for multiple colorectal metastases according to the margin of the largest lesion. Ann Surg Oncol. 2017;24:2438–46.CrossRef Sasaki K, Margonis GA, Maitani K, Andreatos N, Wang J, Pikoulis E, et al. The prognostic impact of determining resection margin status for multiple colorectal metastases according to the margin of the largest lesion. Ann Surg Oncol. 2017;24:2438–46.CrossRef
8.
go back to reference Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis. Ann Surg. 2018;267:1047–55.CrossRef Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis. Ann Surg. 2018;267:1047–55.CrossRef
9.
go back to reference Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.CrossRef Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.CrossRef
10.
go back to reference Hamady ZZR, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JPA. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol. 2006;32:557–63.CrossRef Hamady ZZR, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JPA. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol. 2006;32:557–63.CrossRef
11.
go back to reference Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB. 2011;13:774–82.CrossRef Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB. 2011;13:774–82.CrossRef
12.
go back to reference Tomassini F, Bonadio I, Smeets P, De Paepe K, Berardi G, Ferdinande L, et al. Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins. Langenbeck’s Arch Surg. 2015;400:683–91.CrossRef Tomassini F, Bonadio I, Smeets P, De Paepe K, Berardi G, Ferdinande L, et al. Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins. Langenbeck’s Arch Surg. 2015;400:683–91.CrossRef
13.
go back to reference Torzilli G, Viganò L, Gatti A, Costa G, Cimino M, Procopio F, et al. Twelve-year experience of “radical but conservative” liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy. HPB. 2017;19:775–84.CrossRef Torzilli G, Viganò L, Gatti A, Costa G, Cimino M, Procopio F, et al. Twelve-year experience of “radical but conservative” liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy. HPB. 2017;19:775–84.CrossRef
14.
go back to reference Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef
15.
go back to reference Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef
16.
go back to reference Kaibori M, Shimizu J, Hayashi M, Nakai T, Ishizaki M, Matsui K, et al. Late-onset bile leakage after hepatic resection. Surg. 2015;157:37–44.CrossRef Kaibori M, Shimizu J, Hayashi M, Nakai T, Ishizaki M, Matsui K, et al. Late-onset bile leakage after hepatic resection. Surg. 2015;157:37–44.CrossRef
17.
go back to reference Viganò L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G, et al. Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort Ann Surg Oncol. 2016;23:1352–60.CrossRef Viganò L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G, et al. Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort Ann Surg Oncol. 2016;23:1352–60.CrossRef
18.
go back to reference Hiroyoshi J, Arita J, Gonoi W, Akamatsu N, Kaneko J, Hasegawa K. Significance of Glisson’s capsule invasion in patients with colorectal liver metastases undergoing resection. Am J Surg. 2019;218:887–93.CrossRef Hiroyoshi J, Arita J, Gonoi W, Akamatsu N, Kaneko J, Hasegawa K. Significance of Glisson’s capsule invasion in patients with colorectal liver metastases undergoing resection. Am J Surg. 2019;218:887–93.CrossRef
19.
go back to reference Knijn N, de Ridder JA, Punt CJ, de Wilt JH, Nagtegaal ID. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology. 2013;63:149–56.CrossRef Knijn N, de Ridder JA, Punt CJ, de Wilt JH, Nagtegaal ID. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology. 2013;63:149–56.CrossRef
20.
go back to reference Ungureanu BS, Sǎndulescu L, Şurlin V, Spârchez Z, Sǎftoiu A. Surgical hepatic resection vs ultrasonographic guided radiofrequency ablation in colorectal liver metastases: what should we choose? Med Ultrason. 2014;16:145–51.CrossRef Ungureanu BS, Sǎndulescu L, Şurlin V, Spârchez Z, Sǎftoiu A. Surgical hepatic resection vs ultrasonographic guided radiofrequency ablation in colorectal liver metastases: what should we choose? Med Ultrason. 2014;16:145–51.CrossRef
21.
go back to reference Beppu T, Horino K, Komori H, Sugiyama S, Masuda T, Hayashi H, et al. Thermal ablation for colorectal liver metastases. Therm Med. 2008;24:83–9.CrossRef Beppu T, Horino K, Komori H, Sugiyama S, Masuda T, Hayashi H, et al. Thermal ablation for colorectal liver metastases. Therm Med. 2008;24:83–9.CrossRef
22.
go back to reference Behrouzkia Z, Joveini Z, Keshavarzi B, Eyvazzadeh N, Aghdam RZ. Hyperthermia: how can it be used? Oman Med J. 2016;31:89–97.CrossRef Behrouzkia Z, Joveini Z, Keshavarzi B, Eyvazzadeh N, Aghdam RZ. Hyperthermia: how can it be used? Oman Med J. 2016;31:89–97.CrossRef
23.
go back to reference Itano O, Ikoma N, Takei H, Oshima G, Kitagawa Y. The superficial precoagulation, sealing, and transection method: A “bloodless” and “ecofriendly” laparoscopic liver transection technique. Surg Laparosc Endosc Percutan Tech. 2015;25:e33-36.CrossRef Itano O, Ikoma N, Takei H, Oshima G, Kitagawa Y. The superficial precoagulation, sealing, and transection method: A “bloodless” and “ecofriendly” laparoscopic liver transection technique. Surg Laparosc Endosc Percutan Tech. 2015;25:e33-36.CrossRef
24.
go back to reference Hirokawa F, Hayashi M, Miyamoto Y, Iwamoto M, Tsunematsu I, Asakuma M, et al. A novel method using the VIO soft-coagulation system for liver resection. Surgery. 2011;149:438–44.CrossRef Hirokawa F, Hayashi M, Miyamoto Y, Iwamoto M, Tsunematsu I, Asakuma M, et al. A novel method using the VIO soft-coagulation system for liver resection. Surgery. 2011;149:438–44.CrossRef
25.
go back to reference Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg. 2016;263:146–52.CrossRef Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg. 2016;263:146–52.CrossRef
26.
go back to reference Matsuoka H, Morise Z, Tanaka C, Hayashi T, Ikeda Y, Maeda K, et al. Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer—a retrospective observational study. World J Surg Oncol. 2019;17:33.CrossRef Matsuoka H, Morise Z, Tanaka C, Hayashi T, Ikeda Y, Maeda K, et al. Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer—a retrospective observational study. World J Surg Oncol. 2019;17:33.CrossRef
Metadata
Title
Resection strategy for colorectal liver metastasis focusing on intrahepatic vessels and resection margins
Authors
Kentaro Iwaki
Satoshi Kaihara
Koji Kitamura
Kenji Uryuhara
Publication date
01-09-2021
Publisher
Springer Singapore
Published in
Surgery Today / Issue 9/2021
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-021-02254-0

Other articles of this Issue 9/2021

Surgery Today 9/2021 Go to the issue